Molecular epidemiology of Burkholderia species

被引:44
作者
Coenye, T [1 ]
LiPuma, JJ [1 ]
机构
[1] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2003年 / 8卷
关键词
Burkholderia; B; cepacia; cystic fibrosis; genotyping; epidemiology; review;
D O I
10.2741/937
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although most species in the genus Burkholderia are not pathogenic for healthy persons, a few are capable of causing severe, life threatening infection. B. mallei and B. pseudomallei are the causative agents of glanders and melioidosis, respectively. Interest in these species has increased recently owing to their potential for use as agents of bioterrorism. B. cepacia emerged during the past two decades as an important opportunistic pathogen among persons with certain underlying diseases. Persons with chronic granulomatous disease, a primary immunodeficiency, or cystic fibrosis (CF), the most common lethal inherited disorder in Caucasians, are at particular risk. In CF, respiratory tract infection may be chronic or associated with a rapid deterioration in pulmonary function. Studies in the early 1990s utilized a variety of genotyping techniques to provide compelling evidence of person-to-person transmission of B. cepacia among CF patients. This prompted the institution of rigorous infection control measures that have placed a heavy burden on persons with CF. More recent work has demonstrated that several distinct bacterial species actually exist among bacteria previously identified merely as B. cepacia. How these species, collectively referred to as the B. cepacia complex, differ with respect to their epidemiology, natural history, and pathology in CF is the subject of ongoing investigation.
引用
收藏
页码:E55 / E67
页数:13
相关论文
共 177 条
[1]   Burkholderia cepacia complex infection in Italian patients with cystic fibrosis:: Prevalence, epidemiology, and genomovar status [J].
Agodi, A ;
Mahenthiralingam, E ;
Barchitta, M ;
Gianninò, V ;
Sciacca, A ;
Stefani, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (08) :2891-2896
[2]   Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden [J].
Ahlin, A ;
DeBoer, M ;
Roos, D ;
Leusen, J ;
Smith, CIE ;
Sundin, U ;
Rabbani, H ;
Palmblad, J ;
Elinder, G .
ACTA PAEDIATRICA, 1995, 84 (12) :1386-1394
[3]  
ARBEIT RD, 1995, MANUAL CLIN MICROBIO
[4]   Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex -: Survival linked to genomovar type [J].
Aris, RM ;
Routh, JC ;
LiPuma, JJ ;
Heath, DG ;
Gilligan, PH .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (11) :2102-2106
[5]   Burkholderia cepacia genomovar III is a common plant-associated bacterium [J].
Balandreau, J ;
Viallard, V ;
Cournoyer, B ;
Coenye, T ;
Laevens, S ;
Vandamme, P .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2001, 67 (02) :982-985
[6]   PSEUDOBACTEREMIA ATTRIBUTED TO CONTAMINATION OF POVIDONE-IODINE WITH PSEUDOMONAS-CEPACIA [J].
BERKELMAN, RL ;
LEWIN, S ;
ALLEN, JR ;
ANDERSON, RL ;
BUDNICK, LD ;
SHAPIRO, S ;
FRIEDMAN, SM ;
NICHOLAS, P ;
HOLZMAN, RS ;
HALEY, RW .
ANNALS OF INTERNAL MEDICINE, 1981, 95 (01) :32-36
[7]   Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection [J].
Berriatua, E ;
Ziluaga, I ;
Miguel-Virto, C ;
Uribarren, P ;
Juste, R ;
Laevens, S ;
Vandamme, P ;
Govan, JRW .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (03) :990-994
[8]   Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy:: Genomovar status and distribution of traits related to virulence and transmissibility [J].
Bevivino, A ;
Dalmastri, C ;
Tabacchioni, S ;
Chiarini, L ;
Belli, ML ;
Piana, S ;
Materazzo, A ;
Vandamme, P ;
Manno, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :846-851
[9]   USE OF RIBOTYPING IN EPIDEMIOLOGIC SURVEILLANCE OF NOSOCOMIAL OUTBREAKS [J].
BINGEN, EH ;
DENAMUR, E ;
ELION, J .
CLINICAL MICROBIOLOGY REVIEWS, 1994, 7 (03) :311-327
[10]   ARBITRARILY PRIMED POLYMERASE CHAIN-REACTION AS A RAPID METHOD TO DIFFERENTIATE CROSSED FROM INDEPENDENT PSEUDOMONAS-CEPACIA INFECTIONS IN CYSTIC-FIBROSIS PATIENTS [J].
BINGEN, EH ;
WEBER, M ;
DERELLE, J ;
BRAHIMI, N ;
LAMBERTZECHOVSKY, NY ;
VIDAILHET, M ;
NAVARRO, J ;
ELION, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (10) :2589-2593